Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Mar;102(3):627–630. doi: 10.1111/j.1476-5381.1991.tb12223.x

Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas.

G Bertrand 1, J Chapal 1, R Puech 1, M M Loubatières-Mariani 1
PMCID: PMC1917920  PMID: 1364829

Abstract

1. The effects of a P2 purinoceptor agonist, adenosine 5'-O-(2-thiodiphosphate) (ADP-beta-S) have been studied on insulin secretion and flow rate of the isolated perfused pancreas of the rat. 2. In the presence of a moderately stimulating glucose concentration (8.3 mM), ADP-beta-S (4.95-495 nM) evoked a biphasic insulin response in a concentration-dependent manner. A comparison of relative potency between ADP-beta-S and adenosine 5'-triphosphate (ATP) showed that ADP-beta-S was 100 times more potent than ATP. On the other hand, in the presence of a non stimulatory glucose concentration (4.2 mM), ADP-beta-S (165 nM) did not modify the basal insulin secretion. 3. ADP-beta-S, at concentrations effective on insulin secretion and also at higher concentrations (1.65 and 16.5 microM), provoked an increase of the pancreatic flow rate in a concentration-dependent manner. 4. Our results show that ADP-beta-S is a potent insulin secretory P2 purinoceptor agonist. As it is resistant to hydrolysis it might be useful in studying the effect of activation of the P2 purinoceptor of beta cells on insulin secretion in vivo.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrand G., Chapal J., Loubatieres-Mariani M. M. Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion. Am J Physiol. 1986 Oct;251(4 Pt 1):E416–E421. doi: 10.1152/ajpendo.1986.251.4.E416. [DOI] [PubMed] [Google Scholar]
  2. Bertrand G., Chapal J., Loubatières-Mariani M. M., Roye M. Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed. Br J Pharmacol. 1987 Aug;91(4):783–787. doi: 10.1111/j.1476-5381.1987.tb11276.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bertrand G., Gross R., Chapal J., Loubatières-Mariani M. M. Difference in the potentiating effect of adenosine triphosphate and alpha, beta-methylene ATP on the biphasic insulin response to glucose. Br J Pharmacol. 1989 Nov;98(3):998–1004. doi: 10.1111/j.1476-5381.1989.tb14631.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyer J. L., Downes C. P., Harden T. K. Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides. J Biol Chem. 1989 Jan 15;264(2):884–890. [PubMed] [Google Scholar]
  5. Burnstock G., Cusack N. J., Meldrum L. A. Effects of phosphorothioate analogues of ATP, ADP and AMP on guinea-pig taenia coli and urinary bladder. Br J Pharmacol. 1984 Jun;82(2):369–374. doi: 10.1111/j.1476-5381.1984.tb10771.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  7. Burnstock G. Local control of blood pressure by purines. Blood Vessels. 1987;24(3):156–160. doi: 10.1159/000158691. [DOI] [PubMed] [Google Scholar]
  8. Chapal J., Loubatieres-Mariani M. M. Effects of phosphate-modified adenine nucleotide analogues on insulin secretion from perfused rat pancreas. Br J Pharmacol. 1981 May;73(1):105–110. doi: 10.1111/j.1476-5381.1981.tb16778.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chapal J., Loubatieres-Mariani M. M. Evidence for purinergic receptors on vascular smooth muscle in rat pancreas. Eur J Pharmacol. 1983 Mar 4;87(4):423–430. doi: 10.1016/0014-2999(83)90081-x. [DOI] [PubMed] [Google Scholar]
  10. Fedan J. S., Hogaboom G. K., O'Donnell J. P. Further comparison of contractions of the smooth muscle of the guinea-pig isolated vas deferens induced by ATP and related analogs. Eur J Pharmacol. 1986 Oct 7;129(3):279–291. doi: 10.1016/0014-2999(86)90438-3. [DOI] [PubMed] [Google Scholar]
  11. Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem J. 1986 Jan 15;233(2):309–319. doi: 10.1042/bj2330309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  13. Hourani S. M., Welford L. A., Loizou G. D., Cusak N. J. Adenosine 5'-(2-fluorodiphosphate) is a selective agonist at P2-purinoceptors mediating relaxation of smooth muscle. Eur J Pharmacol. 1988 Feb 16;147(1):131–136. doi: 10.1016/0014-2999(88)90642-5. [DOI] [PubMed] [Google Scholar]
  14. Loubatieres-Mariani M. M., Chapal J., Lignon F., Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol. 1979 Nov 16;59(3-4):277–286. doi: 10.1016/0014-2999(79)90291-7. [DOI] [PubMed] [Google Scholar]
  15. Loubatières A., Mariani M. M., Ribes G., de Malbosc H., Chapal J. Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. Diabetologia. 1969 Feb;5(1):1–10. doi: 10.1007/BF01212212. [DOI] [PubMed] [Google Scholar]
  16. Pearson J. D., Gordon J. L. P2 purinoceptors in the blood vessel wall. Biochem Pharmacol. 1989 Dec 1;38(23):4157–4163. doi: 10.1016/0006-2952(89)90509-1. [DOI] [PubMed] [Google Scholar]
  17. Ralevic V., Burnstock G. Actions mediated by P2-purinoceptor subtypes in the isolated perfused mesenteric bed of the rat. Br J Pharmacol. 1988 Oct;95(2):637–645. doi: 10.1111/j.1476-5381.1988.tb11686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ribes G., Bertrand G., Petit P., Loubatières-Mariani M. M. Effects of 2-methylthio ATP on insulin secretion in the dog in vivo. Eur J Pharmacol. 1988 Oct 11;155(1-2):171–174. doi: 10.1016/0014-2999(88)90418-9. [DOI] [PubMed] [Google Scholar]
  19. Soulaymani R., Gross R., Chapal J., Loubatières-Mariani M. M. Effet dilatateur de l'adénosine sur les vaisseaux du pancréas de rat. C R Seances Soc Biol Fil. 1985;179(3):371–374. [PubMed] [Google Scholar]
  20. Welford L. A., Cusack N. J., Hourani S. M. ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor. Eur J Pharmacol. 1986 Oct 7;129(3):217–224. doi: 10.1016/0014-2999(86)90431-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES